The custom peptide synthesis department of Smartox is pleased to have contributed to the research on TCTP (Translationally Controlled Tumor Protein), a protein implied in cancers.
Thébault S., et al. (2016) TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL. Nature Sci Rep. PMCID: PMC4728560